 Maria Caino
Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 18 | 2024 | 854 | 3.370 |
Why?
| | Mitochondrial Proteins | 6 | 2024 | 245 | 1.740 |
Why?
| | Neoplasm Metastasis | 7 | 2024 | 616 | 1.550 |
Why?
| | Neoplasms | 13 | 2024 | 2475 | 1.530 |
Why?
| | rho GTP-Binding Proteins | 2 | 2024 | 62 | 1.400 |
Why?
| | Mitochondrial Dynamics | 6 | 2022 | 37 | 1.300 |
Why?
| | Vesicular Transport Proteins | 3 | 2018 | 84 | 1.190 |
Why?
| | Prostatic Neoplasms | 5 | 2024 | 1013 | 1.130 |
Why?
| | Nerve Tissue Proteins | 4 | 2019 | 568 | 1.070 |
Why?
| | Myosins | 2 | 2024 | 133 | 1.050 |
Why?
| | Protein Kinase C-epsilon | 5 | 2012 | 26 | 0.960 |
Why?
| | Neoplasm Invasiveness | 6 | 2024 | 480 | 0.950 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2024 | 91 | 0.910 |
Why?
| | Neoplasm Proteins | 4 | 2020 | 421 | 0.750 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 4 | 2013 | 1046 | 0.690 |
Why?
| | Microtubule-Associated Proteins | 2 | 2021 | 190 | 0.680 |
Why?
| | Cell Line, Tumor | 18 | 2024 | 3184 | 0.660 |
Why?
| | Cytoskeleton | 4 | 2018 | 180 | 0.650 |
Why?
| | Cell Movement | 9 | 2023 | 939 | 0.640 |
Why?
| | Signal Transduction | 12 | 2022 | 4838 | 0.620 |
Why?
| | Lung Neoplasms | 5 | 2013 | 2329 | 0.600 |
Why?
| | Membrane Proteins | 6 | 2023 | 1109 | 0.540 |
Why?
| | Cell Proliferation | 8 | 2022 | 2347 | 0.530 |
Why?
| | Enzyme Inhibitors | 3 | 2015 | 811 | 0.490 |
Why?
| | rac GTP-Binding Proteins | 2 | 2012 | 32 | 0.470 |
Why?
| | Protein Kinase C | 3 | 2013 | 253 | 0.440 |
Why?
| | Protein Kinase C-delta | 4 | 2023 | 44 | 0.440 |
Why?
| | Antineoplastic Agents | 5 | 2015 | 2060 | 0.440 |
Why?
| | Liver Neoplasms, Experimental | 1 | 2013 | 28 | 0.430 |
Why?
| | Cellular Senescence | 4 | 2020 | 174 | 0.400 |
Why?
| | Animals | 20 | 2024 | 34600 | 0.390 |
Why?
| | Proto-Oncogene Proteins c-akt | 5 | 2022 | 421 | 0.380 |
Why?
| | Bone Neoplasms | 1 | 2013 | 231 | 0.350 |
Why?
| | Carcinoma | 1 | 2012 | 214 | 0.340 |
Why?
| | Stress, Physiological | 1 | 2013 | 412 | 0.340 |
Why?
| | Mice | 13 | 2024 | 16644 | 0.330 |
Why?
| | NIH 3T3 Cells | 4 | 2020 | 141 | 0.320 |
Why?
| | Humans | 35 | 2024 | 129128 | 0.280 |
Why?
| | Focal Adhesions | 2 | 2019 | 44 | 0.280 |
Why?
| | Dihydroxydihydrobenzopyrenes | 1 | 2006 | 1 | 0.270 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2006 | 19 | 0.270 |
Why?
| | G2 Phase | 1 | 2006 | 36 | 0.270 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 325 | 0.270 |
Why?
| | Energy Metabolism | 4 | 2016 | 836 | 0.260 |
Why?
| | RNA Interference | 6 | 2016 | 441 | 0.250 |
Why?
| | Guanidines | 3 | 2015 | 36 | 0.250 |
Why?
| | A549 Cells | 3 | 2023 | 58 | 0.240 |
Why?
| | Cellular Reprogramming | 2 | 2016 | 95 | 0.240 |
Why?
| | Cell Division | 1 | 2006 | 779 | 0.230 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2016 | 1353 | 0.230 |
Why?
| | Tumor Microenvironment | 3 | 2024 | 622 | 0.230 |
Why?
| | Protein Kinases | 1 | 2006 | 309 | 0.230 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1403 | 0.230 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2023 | 153 | 0.220 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1337 | 0.220 |
Why?
| | MCF-7 Cells | 3 | 2020 | 115 | 0.210 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2015 | 357 | 0.210 |
Why?
| | Enzyme Activation | 4 | 2023 | 799 | 0.210 |
Why?
| | Radiation Tolerance | 1 | 2023 | 97 | 0.200 |
Why?
| | Dynamins | 2 | 2019 | 34 | 0.200 |
Why?
| | HSP90 Heat-Shock Proteins | 2 | 2013 | 45 | 0.200 |
Why?
| | Ubiquitination | 2 | 2023 | 98 | 0.200 |
Why?
| | Peptide Elongation Factors | 1 | 2022 | 15 | 0.200 |
Why?
| | Mice, Nude | 3 | 2016 | 683 | 0.200 |
Why?
| | Neoplasm Transplantation | 2 | 2013 | 258 | 0.190 |
Why?
| | RNA, Small Interfering | 3 | 2013 | 571 | 0.190 |
Why?
| | Sorting Nexins | 1 | 2021 | 10 | 0.190 |
Why?
| | Transport Vesicles | 1 | 2021 | 18 | 0.190 |
Why?
| | Melanoma | 2 | 2020 | 752 | 0.190 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2508 | 0.190 |
Why?
| | Autophagy | 2 | 2021 | 267 | 0.180 |
Why?
| | Coenzyme A Ligases | 1 | 2020 | 13 | 0.170 |
Why?
| | Apoptosis | 6 | 2015 | 2438 | 0.170 |
Why?
| | Trans-Activators | 1 | 2022 | 381 | 0.160 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2019 | 45 | 0.160 |
Why?
| | Myosin Type V | 1 | 2019 | 9 | 0.160 |
Why?
| | Inhibitor of Apoptosis Proteins | 2 | 2016 | 45 | 0.160 |
Why?
| | Aging | 1 | 2009 | 1772 | 0.150 |
Why?
| | Oxidative Phosphorylation | 2 | 2019 | 184 | 0.150 |
Why?
| | RNA-Binding Proteins | 1 | 2022 | 388 | 0.150 |
Why?
| | Androgens | 1 | 2019 | 174 | 0.150 |
Why?
| | Phosphorylation | 5 | 2015 | 1687 | 0.150 |
Why?
| | Myosin Heavy Chains | 1 | 2019 | 173 | 0.140 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2015 | 168 | 0.140 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2020 | 750 | 0.140 |
Why?
| | Glucuronidase | 1 | 2017 | 43 | 0.140 |
Why?
| | Wnt-5a Protein | 1 | 2017 | 21 | 0.140 |
Why?
| | Gene Knockdown Techniques | 2 | 2019 | 312 | 0.140 |
Why?
| | Cell Line | 4 | 2023 | 2737 | 0.140 |
Why?
| | Molecular Targeted Therapy | 2 | 2020 | 387 | 0.140 |
Why?
| | Cell Survival | 4 | 2015 | 1077 | 0.130 |
Why?
| | Endopeptidase Clp | 1 | 2016 | 4 | 0.130 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 471 | 0.130 |
Why?
| | Microtubules | 1 | 2019 | 260 | 0.130 |
Why?
| | Mice, SCID | 2 | 2016 | 347 | 0.130 |
Why?
| | Disease Progression | 2 | 2015 | 2613 | 0.130 |
Why?
| | Lactams, Macrocyclic | 2 | 2013 | 49 | 0.130 |
Why?
| | Thiazolidinediones | 1 | 2017 | 137 | 0.130 |
Why?
| | Isoenzymes | 3 | 2013 | 304 | 0.130 |
Why?
| | Metabolic Networks and Pathways | 1 | 2016 | 175 | 0.120 |
Why?
| | Adaptation, Biological | 1 | 2015 | 56 | 0.120 |
Why?
| | Elafin | 1 | 2015 | 1 | 0.120 |
Why?
| | Male | 11 | 2024 | 63202 | 0.120 |
Why?
| | Fibroblasts | 1 | 2020 | 939 | 0.120 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2017 | 215 | 0.120 |
Why?
| | Phorbol Esters | 2 | 2011 | 14 | 0.110 |
Why?
| | Down-Regulation | 1 | 2016 | 634 | 0.110 |
Why?
| | Tetradecanoylphorbol Acetate | 3 | 2010 | 150 | 0.110 |
Why?
| | Biological Transport | 1 | 2015 | 394 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 872 | 0.110 |
Why?
| | Cell Adhesion | 1 | 2015 | 445 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 1573 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-rel | 1 | 2013 | 7 | 0.110 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2013 | 7 | 0.110 |
Why?
| | Hexokinase | 1 | 2013 | 18 | 0.110 |
Why?
| | Adenylate Kinase | 1 | 2013 | 26 | 0.110 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2013 | 20 | 0.110 |
Why?
| | Mitochondrial Membranes | 1 | 2013 | 38 | 0.100 |
Why?
| | Carcinogens | 2 | 2011 | 110 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2020 | 833 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2024 | 2150 | 0.100 |
Why?
| | Unfolded Protein Response | 1 | 2012 | 52 | 0.100 |
Why?
| | Oxygen Consumption | 1 | 2015 | 675 | 0.100 |
Why?
| | Guanosine Triphosphate | 1 | 2012 | 92 | 0.100 |
Why?
| | Genes, bcl-2 | 1 | 2011 | 20 | 0.100 |
Why?
| | Glioblastoma | 1 | 2015 | 322 | 0.090 |
Why?
| | Up-Regulation | 3 | 2023 | 828 | 0.090 |
Why?
| | Rift Valley fever virus | 1 | 2010 | 2 | 0.090 |
Why?
| | Protein Kinase C-alpha | 2 | 2008 | 37 | 0.090 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 281 | 0.090 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2011 | 162 | 0.090 |
Why?
| | Clinical Trials as Topic | 1 | 2015 | 1000 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 864 | 0.090 |
Why?
| | Etoposide | 1 | 2011 | 150 | 0.090 |
Why?
| | Protein Processing, Post-Translational | 1 | 2013 | 450 | 0.090 |
Why?
| | Insecta | 1 | 2010 | 64 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2013 | 431 | 0.090 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 160 | 0.080 |
Why?
| | Diglycerides | 1 | 2010 | 61 | 0.080 |
Why?
| | GTPase-Activating Proteins | 1 | 2010 | 81 | 0.080 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2011 | 186 | 0.080 |
Why?
| | Promoter Regions, Genetic | 1 | 2013 | 1200 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 757 | 0.080 |
Why?
| | Extracellular Matrix | 1 | 2012 | 498 | 0.070 |
Why?
| | S Phase | 1 | 2007 | 73 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2011 | 686 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 114 | 0.070 |
Why?
| | Checkpoint Kinase 1 | 1 | 2006 | 31 | 0.070 |
Why?
| | Female | 5 | 2024 | 68518 | 0.060 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2006 | 127 | 0.060 |
Why?
| | Brain Neoplasms | 1 | 2015 | 1164 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1192 | 0.060 |
Why?
| | Mice, Inbred NOD | 2 | 2016 | 584 | 0.060 |
Why?
| | DNA Damage | 1 | 2006 | 364 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1689 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2023 | 49 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 92 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2017 | 813 | 0.050 |
Why?
| | Nucleotides | 1 | 2023 | 117 | 0.050 |
Why?
| | Neoplastic Processes | 1 | 2022 | 4 | 0.050 |
Why?
| | Protein Folding | 2 | 2015 | 265 | 0.050 |
Why?
| | Models, Biological | 1 | 2009 | 1695 | 0.050 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2021 | 6 | 0.050 |
Why?
| | Glycolysis | 1 | 2023 | 293 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 41 | 0.050 |
Why?
| | Cytosol | 2 | 2012 | 214 | 0.040 |
Why?
| | Lysosomes | 1 | 2021 | 136 | 0.040 |
Why?
| | Dermis | 1 | 2020 | 31 | 0.040 |
Why?
| | Cell Death | 1 | 2022 | 348 | 0.040 |
Why?
| | Endosomes | 1 | 2021 | 127 | 0.040 |
Why?
| | Voltage-Dependent Anion Channels | 1 | 2019 | 2 | 0.040 |
Why?
| | Muscle Proteins | 1 | 2022 | 229 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2022 | 199 | 0.040 |
Why?
| | Pyruvates | 1 | 2019 | 23 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2019 | 50 | 0.040 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2019 | 42 | 0.040 |
Why?
| | Dihydrotestosterone | 1 | 2019 | 39 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2020 | 225 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 579 | 0.040 |
Why?
| | Keratinocytes | 1 | 2020 | 243 | 0.040 |
Why?
| | Receptors, Androgen | 1 | 2019 | 143 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 983 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2020 | 493 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 2016 | 43 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2016 | 187 | 0.030 |
Why?
| | PPAR gamma | 1 | 2017 | 182 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2016 | 229 | 0.030 |
Why?
| | Protein Subunits | 1 | 2016 | 231 | 0.030 |
Why?
| | Rats | 1 | 2023 | 5173 | 0.030 |
Why?
| | Cyclophilins | 1 | 2015 | 35 | 0.030 |
Why?
| | Cell Cycle | 2 | 2008 | 581 | 0.030 |
Why?
| | Drug Synergism | 1 | 2015 | 358 | 0.030 |
Why?
| | Indoles | 1 | 2017 | 372 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 195 | 0.030 |
Why?
| | Sulfonamides | 1 | 2017 | 500 | 0.030 |
Why?
| | Mutation | 2 | 2017 | 3700 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2012 | 115 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2012 | 131 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 930 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2013 | 356 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2012 | 147 | 0.020 |
Why?
| | Benzophenanthridines | 1 | 2010 | 10 | 0.020 |
Why?
| | Acetophenones | 1 | 2010 | 13 | 0.020 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2012 | 190 | 0.020 |
Why?
| | Vero Cells | 1 | 2010 | 66 | 0.020 |
Why?
| | Benzopyrans | 1 | 2010 | 31 | 0.020 |
Why?
| | bcl-Associated Death Protein | 1 | 2010 | 8 | 0.020 |
Why?
| | Diptera | 1 | 2010 | 28 | 0.020 |
Why?
| | Immunoblotting | 1 | 2010 | 300 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 260 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 374 | 0.020 |
Why?
| | COS Cells | 1 | 2010 | 184 | 0.020 |
Why?
| | Proteomics | 1 | 2016 | 1010 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2012 | 380 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 2765 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3120 | 0.020 |
Why?
| | HeLa Cells | 1 | 2010 | 607 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2010 | 687 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2007 | 75 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5284 | 0.020 |
Why?
| | Adenoviridae | 1 | 2008 | 190 | 0.020 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2010 | 430 | 0.020 |
Why?
| | Proteins | 1 | 2012 | 936 | 0.020 |
Why?
| | Telomerase | 1 | 2007 | 231 | 0.020 |
Why?
| | Middle Aged | 2 | 2017 | 31080 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2016 | 7066 | 0.010 |
Why?
| | Adult | 2 | 2017 | 35513 | 0.010 |
Why?
| | Neurons | 1 | 2010 | 1456 | 0.010 |
Why?
| | Aged | 1 | 2016 | 22090 | 0.010 |
Why?
|
|
Caino's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|